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ABSTRACT 
Measurements that Matter: Assessment and Management of the Symptoms of 
Chronic Illness Using the Integrated Palliative Outcome Scale (IPOS) 
Background: The mission of the Advanced Illness Management (AIM) program at the 
Visiting Nurse Association of Greater St. Louis (VNA) is to relieve the burden of serious 
illness by providing exceptional care to patients and families through symptom 
management. A validated symptom tool was needed for holistic assessment. 
Purpose:  This is a quality-improvement project aimed at enhancing symptom 
management in patients experiencing advanced illness in a community-based palliative 
care program. Provider use of the Integrated Palliative Outcome Scale (IPOS) as an 
assessment tool to deliver focused interventions was explored.  
Methods: The IPOS tool was embedded in the Electronic Health Record (EHR) note 
template. The project used the PICO framework to identify the problem. The Population 
of interest were new patients admitted during a 90 day period. The Intervention of 
interest was the use of the IPOS by providers. The Comparison of interest was the 
absence of the IPOS prior to the project. The Outcome of interest was the use of the IPOS 
and documentation of interventions.  
Results: There were 62 visits in the sample. Compliance rate with use of the tool was 
93.5%. Poor mobility and weakness were the most common physical symptoms. The 
most common psychosocial symptom was the patient’s perception of family anxiety. 
Poor mobility and weakness scored the highest number of aggregate symptoms: 39 and 
37 times respectively. Providers intervened 74% and 76% of the time. While providers 
responded 100% of the time to overwhelming immobility, overwhelming weakness only 
received an intervention 66% of the time. The highest number of psychosocial/spiritual 
symptoms was the patients’ perception of family anxiety. Thirty positive responses were 
recorded with an aggregate score of 76% interventions. The patients’ own anxiety/worry 
was recorded 17 times with an aggregate intervention score of 88%.  
 
Conclusions: Community-based palliative care programs need to be pro-active in the 
management of symptoms to provide holistic patient-centered care.  This project used a 
validated tool that addresses not only the physical burden of chronic illness, but the 
emotional, mental, spiritual, and relationship aspects of illness.  
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Introduction 
 Advanced Illness Management (AIM) is defined as “occurring when one or more 
conditions become serious enough that general health and functioning decline, and 
treatments begin to lose their impact. This is a process that continues to the end of life” 
(American Hospital Assoc., n.d.). Providers of AIM care must have experience in 
assessment, evaluation, diagnosis, and treatment of advanced illness and be 
knowledgeable of cultural and ethical situations involving patients and families. 
Individual providers approach to assessing symptom management created the need for 
consistent documentation which provides information to the interdisciplinary team. The 
Visiting Nurse Association of Greater St. Louis (VNA) has developed a community-
based AIM program that addresses chronic disease in the elderly and disabled adult 
population in the St. Louis metropolitan region. Providers work within an 
interdisciplinary team model to provide quality care with measurable outcomes. The 
program is a team-based consultation co-management program based on a palliative care 
model. Palliative care was eliminated in the title of AIM as the general public has an 
immediate association with end-of-life care and terminal disease. In reality, palliative 
care is for any patient with chronic illness who is experiencing a decreased quality of life 
because of symptoms related to their illnesses or treatments (Mulvihill, 2014). 
Palliative care (PC) is defined as, “Specialty medical care for people living with 
serious illness. It focuses on providing relief from the symptoms and stresses of serious 
illness whatever the diagnosis. The goal is to improve quality of life for both the patient 
and family” (California State University Institute for Palliative Care, n.d.) Patients have a 
high burden of symptoms that may be physical, emotional, spiritual, mental, or 
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relationship/social in nature. In many cases of advanced illness, patients are not eligible 
for hospice or choose not to utilize hospice services if eligible. Patients may seek curative 
treatments concurrent with AIM care. Evidence-based treatments and processes aimed at 
quality improvement are necessary to ensure that care is provided appropriately 
regardless of the trajectory of illness. This paper describes a quality improvement project 
aimed at improving symptom management of patients experiencing advanced illness. A 
symptom tool was needed due to incomplete and inconsistent documentation by 
providers of interventions related to positive symptoms. Provider use of the Integrated 
Palliative Outcome Scale (IPOS) for a select patient population was explored. 
 The VNA community-based AIM Program is a grant-funded project of the 
Missouri Foundation for Health. The mission of the AIM Program is to help relieve the 
burden of serious illness by providing exceptional care to patients and families through 
symptom management. The program prepares patients and families to transition along 
life’s continuum, and prepare for end-of-life when the time is appropriate. Stated goals 
related to grant-funding are that the project demonstrates its ability to provide quality and 
cost-effective care in the area of symptom management. Prior to this project, providers 
were trained to ask about pain, shortness of breath, and sleep habits during visits. These 
answers were “yes” and “no” responses or often not documented. This caused a gap in 
care and limited opportunities for team member follow up. There was no method for 
recording psychosocial symptoms that are important to holistic care. A validated 
assessment tool needed implementation by providers to screen patients for timely 
interventions from the interdisciplinary team. 
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For this project, the IPOS has been embedded in the electronic health record 
(EHR) at a community-based palliative care specialty practice. The purpose of 
incorporating the IPOS into the EHR progress notes was to promote consistency in 
assessment and management of symptoms related to advanced illness by healthcare 
providers on the team. The IPOS tool has been developed over the past 15 years in 
palliative care settings worldwide. Patient related outcome measures (PROMs) are 
measures that reflect quality of life for patients and families dealing with the burdens of 
serious illnesses in the community. Use of IPOS allows providers to respond to PROMs 
by providing timely interventions related to patients’ reported symptoms. 
 The problem statement is: a consistent and systematic holistic symptom 
assessment tool was needed to manage a gap in care. The IPOS is a validated symptom 
tool for management of patients in a community-based palliative care program. The 
PICOT question used to guide this evidence-based project was: “For chronically ill 
patients, will use of a validated symptom tool improve providers’ responses to patient 
symptoms?” The population of interest (P) is all newly enrolled patients in the AIM 
program at the VNA December 1, 2017 – February 28, 2018. The intervention of interest 
(I) is the use of the IPOS tool by providers on all new patients admitted between 
December 1, 2017 – February 28, 2018. The comparison of interest (C) is the absence of 
use of the IPOS at the VNA prior to December 1, 2017. The outcome of interest (O) is 
the use of the IPOS and documentation of interventions (when indicated) by providers for 
the selected population and timeframe. The project was implemented December 1, 2017 – 
February 28, 2018. The first goal of care is stated in the Top Ten Measures that Matter 
(AAHPM, 2015): Palliative care patients receive a comprehensive assessment (physical, 
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psychosocial, social, spiritual, and functional) soon after admission. These goals are 
ongoing in the plan of care for patients. The purpose of this quality improvement project 
was to enhance symptom management for patients in the AIM program. Provider use of 
the IPOS to deliver focused interventions was explored. 
An audit tool was developed to review progress notes on provider visits occurring 
for 90 days on all visits including the initial visit. The selected new patient population 
was followed for 90 days after admission. Patients typically received 4 visits in the 90 
day period after admission. 
Review of the Literature 
 An extensive review of the literature regarding the use of outcome measures for 
control of symptoms in palliative care was done using the following databases: PubMed, 
Medline, CINAHL, Ovid, and Google Scholar. The keywords: palliative care, outcome 
measures, symptom management, symptom management tools, POS, and IPOS were 
used. Search years were 2000 to the present. The search resulted in approximately 90 
documents inclusive of controlled trials, studies, white papers, policy statements, and 
consensus reports. Trials and papers that were conducted in hospital and office-based 
programs were excluded.  
 The literature was also reviewed for palliative care guidelines that provide 
processes for development of quality models. The American Academy of Hospice and 
Palliative Medicine report on Ten Measures to Drive Quality Palliative and Hospice 
Care, AAHPM (2015), provides strong evidence that the development of benchmark 
outcome measures must include validated tools for symptom management. The basis for 
quality palliative care is defined in the National Consensus Project for Quality Palliative 
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Care (Ferrell et al., 2007) and describes the eight domains of care that define palliative 
care. The domains of care should be explored to care for patients and families in a 
holistic team setting. The domains of care identify symptom management as the key 
indicator for successful outcomes. 
In addition to the National Consensus Project for Quality Palliative Care (2013), 
several papers and research studies offer strong evidence that community-based palliative 
care programs are valuable programs in management of patients with serious chronic 
illnesses who have difficulty leaving the home. Cohn et al. (2017) published a discussion 
paper that validates community-based palliative care in the management of chronically ill 
patients. Higginson, Hart, Koffman, Selman, & Harding (2007) conducted a systematic 
review in 2006 that develops the basic need for palliative care as a discipline in 
healthcare. 
In a Cochrane systematic review completed by Gomes, Calazani, Curiale, 
McCrone, and Higginson (2012), the effectiveness and cost-effectiveness of home-based 
palliative care as an option for adults with advanced illness and their caregivers was 
discussed.  The importance of symptom management as it related to quality of life is 
reviewed. Leff, Carlson, Saliba, and Richie’s 2015 article on the state of home-based 
primary and palliative care in the United States (U.S.) led them to create the National 
Home-Based Primary and Palliative Care Network. The authors have developed a 
registry that will be used for quality care benchmarking, practice-based quality 
improvement, performance reporting, and comparative effectiveness research. The main 
focus of the quality of life domain is to optimize symptom management.  
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Lorenz et al. (2006) conducted a systematic review on measures for symptoms 
and advanced care planning in cancer patients. Measures related to pain, dyspnea, 
depression, and advanced care planning are linked to quality of life measures in cancer 
patients. Muldoon, Barger, Flory, and Manuck (1998), discussed quality of life as it 
relates to the personal burden of illness and part of the psychosocial aspects of illness. 
This study is one of the early studies that directed a great deal of research toward quality 
of life issues in palliative care. 
 Bauseweine et al. (2011) interviewed providers to determine usage of outcome 
measures. The results indicate that measurement tools need to be easy to use and 
convenient to interpret to be used consistently. Providers indicated that the most common 
reason that tools are not used is that they do not have time to administer them.  
 The symptoms of serious illnesses dramatically affect the quality of life of 
patients and caregivers. The symptoms associated with serious illness can be physical, 
mental, emotional, spiritual, or psychosocial. This creates the necessity of the use of a 
tool that addresses symptoms in a holistic process. A tool that is validated for use in 
multiple illnesses and with diverse populations was needed to produce data useful to 
providers and results in appropriate interventions. Additionally, a tool that has been 
validated in multilingual settings is needed for diverse cultures and ethnicities. The 
Integrated Palliative Outcome Scale (IPOS) (Appendix) was originally developed at 
King’s College in London, UK. POS: Palliative Outcome Scale (2012) is the IPOS 
precursor and has been tested extensively in Europe and Africa. It has been revised and 
refined over a 15 year validation period. Literature on the validity of the IPOS was 
reviewed to determine its appropriateness for use in a community-based program that 
9 
MEASURES THAT MATTER 
manages multiple serious chronic illnesses in private homes as well as long-term care 
settings.  
 The current literature offers strong evidence that the IPOS is a valid tool for use in 
multi-cultural settings for multiple illnesses in palliative care settings. The following 
studies were reviewed as they relate to IPOS use in various palliative care settings. 
 Evans et al. (2013) assert that PROMs are the most useful outcome measures to 
determine patient quality of life in consensus workshop studies. The Palliative Outcome 
Scale (precursor) to IPOS is specifically cited as a valid tool to measure PROMs. Collins 
et al. (2015) conducted a systematic review of the use of the POS and the Support Team 
Assessment Schedule (STAS), which found support of these as valid tools in a variety of 
palliative care settings. Kane et al. (2017) evaluated the acceptability and feasibility of 
the IPOS in symptom management of heart failure patients in palliative care programs. 
They concluded that the IPOS is a valid tool for symptom management in heart failure. 
This is a notable study due to the high number of heart failure patients in palliative care 
programs.  
 Studies using the POS include the 1999 study by Hearn and Higginson who 
developed a scale to measure the physical, psychological, and/or spiritual domains of 
palliative care and tested it for validity on 450 patients with advanced cancer. This study 
was the basis for continued development of the POS as a validated tool to measure 
symptom burden. Lowther et al. (2012) used the POS in a randomized controlled trial 
(RCT) to measure symptom burden in HIV patients receiving antiretroviral therapy. 
Evans et al. (2013) identify the POS as a valid tool to measure PROMs by international 
experts attending a palliative care and end-of-life consensus workshop. Rugno and 
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Marysia (2016) conducted an integrated literature review of 25 multi-cultural studies that 
validates the importance of the POS in research studies in palliative care. The review also 
included validity of the POS in clinical practice for symptom management. 
 Beck et al. (2017) validated the translation of the IPOS into Swedish. The IPOS 
was successfully adapted cross-culturally in general and specialized palliative care. 
Schildmann et al. (2015) validated the translation of the IPOS into German. Results from 
these studies also validate that the tool is acceptable translated into specific cultural 
settings.  
 In 2016, Gao et al. used the IPOS with additional neurological emphasis 
successfully in a small study. This validated that the IPOS can be modified for use in 
specific patient populations. A specific IPOS for patients with progressive long-term 
neurological illnesses showed reasonable correlation with the original POS. The use of a 
specific IPOS tool for research purposes in monitoring outcomes over time in 
neurological diseases shows promise for detecting subtle progression of illness and slow 
decline. 
 Kane et al. (2017) used the IPOS in a large heart failure study that not only 
validated outcome measures, but a high compliance of provider use was recorded. The 
heart failure study had two parts. The first included education and training on patient-
centered care, and the second part trained nurses on the use of the IPOS for heart failure 
patients. Murtagh et al. (2016) showed that the IPOS has good test-retest reliability and 
internal consistency. The IPOS was used in a Cochrane controlled trial for patients 
completing the questionnaire with their caregiver proxies. Clinical relevance was 
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established by higher scores by both patients and proxies in unstable or deteriorating 
disease states. 
 The IPOS literature review includes strong evidence that the IPOS is a valid tool 
in palliative care specialties for measurement of the burden of symptoms. The IPOS was 
developed from the POS integrating the most clinically relevant aspects of quality of life. 
Symptoms may be physical, mental, emotional, spiritual, or psychosocial in nature. The 
tool has also been validated for use in multiple types of serious and/or chronic illnesses. 
The IPOS has been extensively used in studies conducted in Europe and Africa. There are 
gaps in studies on the use of the IPOS in the U.S. There is also a gap in studies that 
involve individuals affected by advanced dementia. 
Framework of the Study 
 The framework of this study is the Plan, Do, Study, Act framework (Institute for 
Healthcare Improvement, n.d.) In the Plan phase, research was done on the validity of the 
IPOS as it not only addressed physical symptoms, but contained narratives necessary to 
understand the emotional, spiritual, psychosocial, mental, and relationship needs of 
patients and families facing serious and/or chronic illnesses in the community. Also, 
during the Plan phase, rights were obtained to use the tool in the practice setting and for 
research purposes. The information technology support team was engaged in the project 
to embed the tool into the EHR as a custom report that would allow quick and easy 
access by providers. The IPOS appears in the provider progress note and requires 
approximately five minutes to complete. Results can be exported to custom reports after 
de-indentification for recording and research purposes. 
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 In the Do phase, training sessions for providers was accomplished in two sessions 
to provide adequate opportunity to discuss the use and importance of the tool in the 
practice to provide high quality of care to patients and families. The go-live date of 
December 1, 2017 was chosen to allow a 90 day period of collection for retrospective 
review on use and associated interventions in positive symptom burdens. Consistent use 
of the tool and interventions were audited following the initial period of use. 
 A 90-day Study phase began at the go-live date. Providers were instructed that the 
IPOS should be used during each visit on any newly admitted patient to the VNA AIM 
program from December 1, 2017 – February 28, 2018.  Patients in the study were audited 
for all visits done in the 90 days following their admission.   
 After the 90-day Study, results of the audit were reviewed during the Act phase. 
The Act phase began with an EHR review of the target patient population. Provider notes 
were reviewed for appropriate use of the IPOS and documentation of corresponding 
interventions when indicated. Retraining and continued education of the providers will be 
done post-audit via team meetings to reiterate the significance of symptom management 
and to discuss implementation of goals of care six months following the audit period. 
Method 
Design 
This is a quality improvement project. Retrospective chart audits were completed. 
The IPOS was used by clinical providers during visits on all new patients in the AIM 
program. Patients included in this project were admitted as new patients between 
December 1, 2017 and February 28, 2018. Documentation of results of the IPOS was 
recorded in the patient’s EHR during the provider visit. The provider verbally read the 
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questions to the patient during the visit and recorded the answers. The go-live date for 
implementation of the project was December 1, 2017. Beginning June 1, 2018, eligible 
patient EHRs were audited for provider compliance in the use of the IPOS and 
documentation of corresponding interventions for positive responses. Caregiver 
assistance if given, was documented on the IPOS. 
Setting 
 The setting for the project was a community-based palliative care specialty 
practice. Patients were primarily over 65 years of age or disabled adults who were 
enrolled in VNA of Greater St. Louis AIM program. The patients or an approved 
designee signed consent forms to be treated by the providers and interdisciplinary team 
members of the AIM program. Provider visits occurred in the patient’s primary residence, 
which may be a private home, long-term facility or senior housing.  
Sample  
The target population for this quality improvement project was all new patients 
admitted to the AIM program between December 1, 2017 and February 28, 2018. Patients 
qualifying for the program were 65 years and older or disabled adults with one or more 
chronic and/or serious illnesses. Patients were insured by Medicare, Medicaid or 
sponsored by the VNA. Patients were not excluded due to gender, race, ethnicity or 
sexual orientation. Patients who scored less than 7 on the 10-point cognitive screen with 
the Rapid Geriatric Assessment Tool (RGAT) (St. Louis University, 2016) were excluded 
from this project. The patient sample size was 17 patients. Each patient received 
approximately 4 visits in the 90 day intervention period. Patients who transitioned out of 
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the program during the audit period, received less than 4 visits.  All chart audits were 
completed by the project director with the audit tool created for this project.  
Approval Processes 
 Providers of care and interdisciplinary team members have been notified of the 
study and the go-live date for use of the IPOS. Consent of the patient or approved legal 
designee to participate in the AIM program is obtained on admission. This is a non-
invasive intervention. Information obtained from the tool will be used to improve the 
delivery and quality of care related to symptom management in advanced illness. The 
project was approved by the University of Missouri – St. Louis Institutional Review 
Board. 
Data Collection/Analysis 
  Chart reviews for provider compliance with the use of the IPOS for assessment 
and management of symptoms related to the burden of serious illness were conducted by 
the project director on encrypted computers in a cloud-based EHR. A de-identified 
number was assigned by the auditor to each patient audited. Audits of patient records 
were performed using the EHR by the auditor authorized to use the system. The de-
identified audit tools were paper records stored in locked cabinet at the VNA office. All 
chart audits occurred at that location. Compliance with the use of the IPOS tool and 
documentation of corresponding interventions for positive responses was recorded on the 
audit tool. The audit results will be used to improve care delivery and the quality of life 
for patients experiencing advanced illness.  
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Procedures 
 This is a quality improvement project that included a retrospective chart review 
on all new patients enrolled in the AIM program at VNA of Greater St. Louis between 
December 1, 2017 and February 28, 2018. Patient provider visits occurring 90 days 
following the initial enrollment received chart reviews by the project director. The audit 
tool was developed by the project director to mirror the symptoms on the IPOS tool.  
 The following was evaluated per the audit tool: provider use of the IPOS, patient 
responses, and provider documentation of corresponding interventions when indicated. 
Patient responses to inquiries about pain, shortness of breath, weakness, nausea, 
vomiting, poor appetite, constipation, sore or dry mouth, drowsiness, and poor mobility 
that were recorded as “Moderately,” “Severely,” or “Overwhelmingly,” should have a 
corresponding intervention. Additionally, patient responses to “other” symptoms 
recorded as “Moderately” or greater should have a corresponding intervention. Patient 
responses to questions related to the last 3 days prior to use of the IPOS regarding patient 
anxiety, family anxiety, and patient depression should have a provider intervention to 
responses of “Most of the time” or “Always”. Patient responses to questions about feeling 
at peace, sharing feelings with family and friends, and having as much information as 
wanted should have a corresponding intervention recorded in the Plan section if the 
response is “Occasionally” or “Almost never”. Patient responses of “Problems hardly or 
never addressed” to the question regarding financial or personal problems addressed 
should have a corresponding intervention in the Plan section. The audit tool recorded the 
patient’s diagnosis, but no identifying demographics. Each provider in the AIM program 
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who participated in this project was assigned an identifier to assess patterns of variability 
across providers and for individual education purposes. The end goal is the delivery of 
consistent, quality care.  
Results 
Table 1 Patient PopulationTotals 
 
 
Total patients in project 
 
17 
  
Number of Initial Visits in project 17 
Second Visits 15 
Third Visits 15 
 Fourth Visits 12 
 Fifth Visits 3 
Total Visits 62 
Total Visits using IPOS resulting in 
93.5% compliance during audit 
58 
 
 During the 90-day enrollment period, 20 new patients were enrolled to the AIM 
program. Three patients were excluded due to cognitive scores below seven on St. Louis 
University’s RGAT, (St. Louis University 2016). The sample for this project was 17. 
There were 62 visits in the sample and 58 of these had completed IPOS. This is a 93.5% 
compliance rate of providers’ use of the tool.  
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 An unexpected result was that five patients transitioned to end-of-life care before 
the 90-day audit ended. These patients did not receive the expected four visits in the 
period. 
Table 2 Patient Population by Diagnosis 
Primary Diagnosis   
CHF 6 35% 
Cancer (all sites) 4 24% 
COPD/Asthma 2 12% 
Interstitial Lung Disease 2 12% 
Other 3 17% 
 
 Patient population results showed 35% were admitted with a primary diagnosis of 
Congestive Heart Failure (CHF). 24% were admitted with cancer, and 24% with lung 
diseases (Chronic Obstructive Pulmonary Disease, COPD was 12% and interstitial lung 
disease was 12%). The remaining 17% included caregiver stress, failure to thrive, and 
chronic pain. The majority of the patient population had multiple chronic illnesses that 
were co-managed by the primary care providers.  
The rating scale in the IPOS for symptoms increase as the burden of the symptom 
increases. For physical symptoms, moderate equaled two points, severe equaled three 
points, and overwhelming equaled four points. Poor mobility and weakness were the 
most common physical symptoms, positive more often than pain or shortness of breath.  
These two symptoms were reported in all diagnoses as the most burdensome physical 
symptoms. The audit of interventions in response to physical symptoms was for 
symptoms scored moderately, severely or overwhelmingly.  Patients’ perceptions of 
family anxiety about their illnesses was the most common psychosocial symptom, rated 
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more often than the patients’ own anxiety. Interventions were expected in the audit when 
symptoms were rated most of the time or always. While patient anxiety is addressed 88% 
of the time by providers, family anxiety is addressed 76% of the time. When providers 
asked patients about “Peace,” 17 patient visits recorded that they were only occasionally 
or almost never at peace. Generating meaningful discussions with patients and caregivers 
to concerns about the concept of peace, and referring to spiritual counselors as indicated 
allows patients to begin transitioning to end-of-life care.   
 Provider interventions for aggregate levels of physical symptom burdens ranged 
from 100% for vomiting to 14% for constipation and sore/dry mouth. When constipation 
was scored as moderate with 2 points assigned for each response and intervention, 
moderate constipation was 17% and severe constipation received 0% interventions. 
Moderate sore/dry mouth had 0% interventions and severe sore/dry mouth received 
interventions 43% of the time. Due to the adverse effects of these symptoms on patients’ 
quality of life, education on guidelines and protocols will be reviewed with providers as 
part of future recommendations. 
 Poor mobility and weakness scored the highest number of aggregate symptoms: 
39 and 37 times respectively. Providers intervened 74% and 76% of the time. While 
providers responded 100% of the time to overwhelming immobility, overwhelming 
weakness only received an intervention 66% of the time. Table 3 shows the intervention 
percentages for physical symptoms. Percentages in bold are below the standard of care 
percentages that will be established as a result of this baseline audit. 
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Table 3 Percentage of Interventions in Response to Positive Physical Symptoms 
 # 
Pos. 
Aggregate % Moderate % Severe % Overwhelming % 
Symptom/Goal   85% 90% 95% 
Pain 30 90% 95% 75% 100% 
SOB 29 79% 80% 86% - 
Weakness 37 76% 68% 87% 66% 
Nausea 6 67% 75% 50% - 
Vomiting  1 100% 100% - - 
Poor 
Appetite 
16 50% 33% 71% - 
Constipation 7 14% 17% 0% - 
Sore/Dry 
Mouth 
14 14% 0% 43% - 
Drowsy 16 63% 58% 75% - 
Poor 
Mobility 
39 74% 78% 60% 100% 
Other 8 63% 43% 100% - 
Notes: Percentages in bold are below the proposed 6 month goals of: 
Moderate= Intervention at least 85% of the time. Severe= Intervention at least 90% of 
the time. 
Overwhelming= Intervention at least 95% of the time. 
Items marked with (-) indicate that no data was generated in the audit 
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 The highest number of psychosocial/spiritual symptoms was the patients’ 
perception of family anxiety. Thirty positive responses were recorded with an aggregate 
score of 76% interventions. The patients’ own anxiety/worry was recorded 17 times with 
an aggregate intervention score of 88%  
 
Table 4 Percentage of Interventions in Response to Positive Psychosocial 
Symptoms 
 # Pos. Aggregate % Most of the 
Time % 
Always % 
SYMPTOM/GOAL   90% 95% 
Anxiety/Worry 17 88% 89% 87% 
Family Anxiety 30 76% 75% 78% 
Depressed 13 77% 70% 100% 
     
Notes: Percentages in bold are below the 6 month goal of Intervention at least 
90% for Most of the time, and Intervention at least 95% for Always. 
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Percentage of Interventions in Response to Positive Psychosocial Symptoms 
 # Pos. Aggregate % Occasionally % Not at 
All % 
SYMPTOM/GOAL   90% 95% 
Peace 17 88% 91% 83% 
Family Sharing 7 86% 100% 80% 
Info. Sharing 1 100% 100% None 
     
Notes: Percentages in bold are below the 6 month goal of Intervention at least 
90% for Occasionally, and Intervention at least 95% for Not at All. 
 
 
 
Percentage of Interventions in Response to Positive Psychosocial Symptoms 
 Aggregate % Hardly 
Addressed % 
Never 
Addressed % 
SYMPTOM/GOAL  90% 95% 
Practical 
Problems 
- - - 
Notes: No patient symptoms were reported at these levels on this audit. 
Indicated with (-). 
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Discussion 
 Community-based palliative care programs need to be pro-active in the 
management of symptoms to provide holistic patient-centered care.  This project uses a 
validated tool (IPOS) that addresses not only the physical burden of chronic illness, but 
the emotional, mental, spiritual, and relationship aspects of illness. The project was 
heavily weighted toward the documentation of the full-time AIM providers as they 
perform the majority of the patient visits in the first 90 days. It is by program design that 
the two most experienced providers provide consistent stabilization of patients 
immediately after admission when they are at the highest risk of hospital readmission. An 
unexpected result of patients transitioning to hospice during the audit period decreased 
the expected number of visits during the 90-day audit period. 
 Subsequent audits will need a comprehensive review of all providers as the 
program grows and new providers and census increase. Future training on the use of the 
IPOS needs to incorporate the experience of staff who have consistently administered it 
successfully over the 90-day audit period. Providers consistently used the tool in 93.5% 
of their visits. Incorporating the tool in a conversational review of symptoms often 
generated narrative from patients that aided providers in determining decreased coping by 
patients and/or increased caregiver stress and anxiety. Providers indicated that the tool 
was not too time consuming, and it triggered reminders of documentation of positive 
symptoms.  
This audit will be used to formulate a quality improvement initiative within the 
AIM program to be reviewed 6 months post-baseline audit on individual providers’ 
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intervention response to symptoms. A second 90 day audit will be performed on random 
visits for individual providers after education on the expected percentages of intervention. 
This project provides the AIM program with a valid baseline on provider responsiveness 
to symptom burden in chronically ill patients across all admitting diagnoses. Providers 
administered the IPOS during 93.5% of their visits during the 90-day audit period. The 
goal in six months is to maintain a 95% administration rate for all providers. Goals for 
physical symptoms at 6 months is 95% of patients receive interventions for symptoms 
rated as overwhelming, 90% for symptoms rated severe, and 85% for symptoms rated 
moderate. The six month goal for the psychosocial symptoms of patient anxiety, family 
anxiety and depression rated most of the time is 90% of patients receive interventions and 
if rated always is 95%. Psychosocial symptoms of peace, family sharing of feelings and 
information rated as occasionally receives an intervention 90% of the time, and if rated  
not at all 95%. Problems hardly addressed receive an intervention 90% of the time. 
Problems not addressed receive an intervention 95% of the time. Implementation of these 
goals will guarantee consistent quality of life through timely symptom management. 
Dementia patients scoring less than 7 on the Rapid Geriatric Screen (St. Louis 
University, 2016) were excluded from this project. This exclusion of three patients in the 
90-day audit generates an opportunity to conduct another project using IPOS 
administered to caregiver proxies during visits in comparison to a tool specifically 
designed for dementia patients. 
An integral part of the success of the program is the telephone “touch” calls 
completed by the medical secretary. The IPOS page 1 was integrated into the telephone 
encounter form when doing status checks. This allows consistent management with each 
24 
MEASURES THAT MATTER 
encounter. Consistent themes during a series of encounters allows providers to direct 
interventions toward recurring problems. 
The most common physical symptoms that patients reported were poor mobility 
and weakness. These two symptoms were reported in all diagnoses as the most 
burdensome physical symptoms. The audit of interventions in response to physical 
symptoms was for symptoms scored moderately, severely or overwhelmingly.  Patients’ 
perceptions of family anxiety about their illnesses was the most common psychosocial 
symptom, rated more often than the patients’ own anxiety. Interventions were expected in 
the audit when symptoms were rated most of the time or always. While patient anxiety is 
addressed 88% of the time by providers, family anxiety is addressed 76% of the time. 
When providers asked patients about “Peace,” 17 patients stated that they were only 
occasionally or almost never at peace. Generating meaningful discussions with patients 
and caregivers to concerns about the concept of peace, and referring to spiritual 
counselors as indicated allows patients to begin transitioning to end-of-life care.  
 Education for providers on the availability of resources that can easily be 
accessed is indicated from the low intervention scores on some symptoms. This resource 
list would include all AIM and community partners to be used as resources when positive 
physical and psychosocial symptoms are noted. These team and partner resources may 
include behavioral health, physical and occupational therapy, home infusion, laboratory 
and radiology home services, and many others. Part of the commitment to effective home 
management is a network of services to address symptoms in all domains of care. 
The next step in improving the quality of care is re-educating providers on the 
importance of interventions relating to positive symptoms expressed by patients. 
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Interdisciplinary team members need education on interpretation of positive symptoms 
revealed in their domains of specialty. Integration of the IPOS for tracking outcomes over 
time increases the importance of corresponding interventions to provide quality care over 
time. The symptoms addressed in IPOS page 1 have already been embedded in the 
telephone encounter form. This extends the opportunity of addressing the possibility of 
positive symptoms at every encounter with the AIM team. Future projects include 
researching guidelines and best practices for managing individual symptoms that 
emerged in common themes from this project in order to provide consistent interventions 
among providers. 
Guidelines can be inserted in the patient’s care plan. They include pharmaceutical 
and non-pharmaceutical teaching interventions. Implementation of these guidelines and 
best-practices help establish patient-centered goals of care and empower patients’ and 
families’ autonomy. 
Conclusion 
Community-based programs managing chronic illnesses as specialty palliative 
care is a new and growing concept in U.S. healthcare. The AIM program in St. Louis is 
funded by the Missouri Foundation for Health to test quality, patient satisfaction, and 
cost-effectiveness. AIM will not only be judged using the Institute for Healthcare 
Improvement’s Triple Aim of improving the health of populations, patient-centered care, 
and cost-effectiveness, (Institute for Healthcare Improvement, n.d.), but for sustainability. 
Outcomes can be improved by effective symptom management that satisfies the Institute 
of Medicine’s goals for the patient’s experience of care: safe, effective, efficient, timely, 
equitable, and patient-centered (Institute of Medicine, 2016). Data collected from IPOS 
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audits will drive guidelines and best-practice information to assist providers in providing 
consistent, quality patient care. Information will be obtained from Joint Commission, 
Institute of Medicine, and the Center for the Advancement of Palliative Care to assist in 
certification of the AIM program as the specialty grows in U.S. healthcare programs.  
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Appendix  
IPOS Patient Version 
 
Patient name  : ………………………………………………… 
Date (dd/mm/yyyy) : ………………………………………………… 
Patient number : ………………………………… (For staff use) 
 
Q1. What have been your main problems or concerns over the 
past 3 days? 
1. 
............................................................................................................ 
2. 
............................................................................................................ 
3. 
............................................................................................................. 
Q2. Below is a list of symptoms, which you may or may not 
have experienced. For each symptom, please tick one box that 
best describes how it has affected you over the past 3 days.   
 
 
Not at 
all 
Slightly 
Moderat-
ely 
Severely 
 
 
Over-
whelmingly 
 
Pain 0 1 2 3 4 
Shortness of 
breath 0 1 2 3 4 
Weakness or 
lack of energy 0 1 2 3 4 
Nausea (feeling 
like you are going 
to be sick) 
0 1 2 3 4 
Vomiting 
(being sick) 0 1 2 3 4 
Poor appetite 0 1 2 3 4 
Constipation 0 1 2 3 4 
Sore or dry 
mouth 0 1 2 3 4 
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Drowsiness 0 1 2 3 4 
Poor mobility 0 1 2 3 4 
 
Please list any other symptoms not mentioned above, and tick 
one box to show how they have affected you over the past 3 
days. 
1. 0 1 2 
3
 4 
2. 0 1 2 
3
 4 
3. 0 1 2 
3
 4 
 
 
 
 
 
 
 
Over the past 3 days: 
 
 
 
 
 
 
 
Not at 
all 
Occasionally Sometimes 
Most of 
the time 
Always 
Q3. Have you 
been feeling 
anxious or 
worried about 
your illness or 
treatment? 
0 1 2 3 4 
Q4. Have any of 
your family or 
friends been 
anxious or 
worried about 
you? 
0 1 2 3 4 
Q5. Have you 
been feeling 
depressed? 
0 1 2 3 4 
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Always 
Most of the 
time 
Sometimes Occasionally Not at all 
Q6. Have you felt 
at peace? 0 1 2 3 4 
Q7. Have you 
been able to 
share how you 
are feeling with 
your family or 
friends as much 
as you wanted? 
0 1 2 3 4 
Q8. Have you 
had as much 
information as 
you wanted? 
0 1 2 3 4 
 
Problems 
addressed
/ No 
problems 
Problems 
mostly 
addressed 
Problems 
partly 
addressed 
Problems 
hardly 
addressed 
Problems 
not 
addressed 
Q9. Have 
any practical 
problems 
resulting 
from your 
illness been 
addressed? 
(such as 
financial or 
personal) 
0 1 2 3 4 
 
On my 
own 
With help from a friend or relative 
With help 
from a 
member 
of staff 
Q10. How did 
you complete 
this 
questionnaire? 
   
 
 
If you are worried about any of the issues raised on this questionnaire  
then please speak to your doctor or nurse 
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Appendix 2 
IPOS Audit Tool 
 
Date (dd/mm/yyyy) : ……………………… Admitting 
Diagnosis……………………………. Provider Number: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Visit 1 
Provider 
assessed 
positive 
symptom 
y=yes, 
n=no             
Visit 1 
Provider 
interven-
tion on 
positive 
symptom 
y=yes, 
n=no    
Visit 2 
Provider 
assessed 
positive 
symptom 
y=yes, 
n=no          
    
Visit 2 
Provider 
interven-
tion on 
positive 
symptom 
y=yes, 
n=no    
 
 
 
Visit 3 
Provider 
assessed 
positive 
symptom 
y=yes, 
n=no             
 
  
 
Visit 3 
Provider 
interven-
tion on 
positive 
symptom 
y=yes, 
n=no             
 
 
Visit 4 
Provider 
assessed 
positive 
symptom 
y=yes, 
n=no             
 
 
 
 
 
Visit 4 
Provider  
Interven-
tion 
on positive 
symptom 
y=yes, 
n=no 
          
Pain         
Short-
ness of 
breath         
Weakne
ss or 
lack of 
energy 
        
Nausea 
(feeling 
like you 
are 
going to 
be sick) 
        
Vomiting 
(being 
sick)         
Poor 
appetite         
Constipa
-tion         
Sore or 
dry 
mouth      
 
   
Drowsi-
ness         
Poor 
mobility        
 
 
 
 
 
 
Additional Symptoms 
   
1.      
 
   
2.         
3.         
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Visit 1 
Provider 
assessed 
positive 
symptom 
y=yes, 
n=no    
Visit 1 
Provider 
interven-
tion on 
positive 
symptom 
y=yes, 
n=no    
Visit 2 
Provider 
assessed 
positive 
symptom 
y=yes, 
n=no    
Visit 2 
Provider 
interven-
tion on 
positive 
symptom 
y=yes, 
n=no    
Visit 3         
Provider 
assessed 
positive 
symptom 
y=yes, 
n=no 
Visit 3 
Provider 
interven-
tion on 
positive 
symptom 
y=yes, 
n=no 
Visit 4 
Provider 
assessed 
positive 
symptom 
y=yes, 
n=no 
Visit 4 
Provider 
intervention 
on positive 
symptom 
y=yes, n=no 
Q3. Have 
you been 
feeling 
anxious or 
worried 
about your 
illness or 
treatment? 
        
Q4. Have 
any of your 
family or 
friends 
been 
anxious or 
worried 
about you? 
        
Q5. Have 
you been 
feeling 
depressed? 
        
Q6. Have 
you felt at 
peace? 
        
Q7. Have 
you been 
able to share 
how you are 
feeling with 
your family 
or friends as 
much as you 
wanted? 
          
Q8. Have 
you had as 
much 
informatio
n as you 
wanted? 
        
Q9. Have any 
practical 
problems 
resulting 
from your 
illness been 
addressed? 
(such as 
financial or 
personal) 
        
